Skip to main content
. 2018 Jan 8;8:93. doi: 10.1038/s41598-017-18551-z

Figure 4.

Figure 4

Knockdown of Sema4B reduces tumor formation in vivo using a xenograft model. (AD) Two groups of U87-MG cells were infected with either shRNA lentivirus targeting Sema4B or control and selected for three days before the beginning of the experiment. Each group of cells was injected subcutaneously into nude mice. (A) Macroscopic appearance of xenografts at the end of treatment. (B) Section of xenografts stained with hematoxylin/eosin. Scale bar 100 μm. (C) Change of tumor volume during treatment period. (D) Tumor weight at the end of the treatment. Data represent the means of n = 5 ± s.e.m. The p values were calculated after the data were confirmed to fulfill the criteria with Mann–Whitney U Test: p < 0.005.